Filtros de búsqueda

Lista de obras de Koen van Besien

1581. Impact of Colonization with Fluoroquinolone-Resistant Enterobacteriaceae on the Risk of Gram-Negative Bacteremia in Hematopoietic Stem Cell Transplant Recipients Who Receive Prophylactic Levofloxacin

1589. Increased Detection of Diarrheal Pathogens in Hematopoietic Stem Cell Transplant Recipients Using a Multiplexed PCR Panel

2501. Impact of Influenza A and B Infection on Stem Cell Transplant Patients During the 2017–2018 Season at a Single Center

2695. Pneumocystis jirovecii Pneumonia in the Era of Effective Prophylaxis Following Hematopoietic Stem Cell Transplant

452Pseudo-Outbreak of Fulminant Toxoplasmosis in Hematopoietic Stem Cell Transplant [HSCT] Recipients.

artículo científico publicado en 2014

A Phase I Study of CPX-351 in Combination with Busulfan and Fludarabine Conditioning and Allogeneic Stem Cell Transplantation in Adult Patients with Refractory Acute Leukemia

artículo científico publicado en 2013

A Phase I Trial of High-Dose Lenalidomide and Melphalan as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Multiple Myeloma.

artículo científico publicado en 2017

A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR.

artículo científico publicado en 2009

A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma

artículo científico publicado en 2002

A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease

artículo científico publicado en 2008

A new "age" for high dose therapy and autologous stem cell transplant.

artículo científico publicado en 2015

A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes.

artículo científico publicado en 2013

A novel hematopoietic progenitor cell mobilization and collection algorithm based on preemptive CD34 enumeration

artículo científico publicado en 2015

A phase 1 study of bendamustine and melphalan conditioning for autologous stem cell transplantation in multiple myeloma

scientific article published on 20 February 2013

A phase 2 study of epothilone B analog BMS-247550 (NSC 710428) in patients with relapsed aggressive non-Hodgkin lymphomas

artículo científico publicado en 2013

A renaissance for autologous transplantation in follicular lymphoma?

artículo científico publicado en 2018

Acquired cyclic amegakaryocytic thrombocytopenia associated with an immunoglobulin blocking the action of granulocyte-macrophage colony-stimulating factor

artículo científico publicado en 1989

Addition of Plerixafor to Mobilization Regimens in Autologous Peripheral Blood Stem Cell Transplants Does Not Affect the Correlation of Preharvest Hematopoietic Precursor Cell Enumeration with First-Harvest CD34+ Stem Cell Yield

scientific article published on 13 July 2012

Adoptive Immunotherapy with Cord Blood for the treatment of refractory Acute Myeloid Leukemia: feasibility, safety and preliminary outcomes

scientific article published on 09 November 2018

Adoptive immunotherapy with CB following chemotherapy for patients with refractory myeloid malignancy: chimerism and response

artículo científico publicado en 2020

Advances in mobilization for the optimization of autologous stem cell transplantation

artículo científico publicado en 2009

Alemtuzumab in allogeneic hematopoetic stem cell transplantation

artículo científico publicado en 2011

Allogeneic Hematopoietic Cell Transplantation for Therapy-Related Myeloid Leukemia following Orthotopic Cardiac Transplantation

artículo científico publicado en 2013

Allogeneic Transplant Conditioning Regimens for Patients With Non-Hodgkin Lymphoma

artículo científico publicado en 2020

Allogeneic Transplantation for Patients With Advanced Myelofibrosis: Splenomegaly and High Serum LDH are Adverse Risk Factors for Successful Engraftment

artículo científico publicado en 2016

Allogeneic and autologous transplantation for chronic lymphocytic leukemia

artículo científico publicado en 2001

Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia

artículo científico publicado en 2002

Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease

artículo científico publicado en 1997

Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts

scientific article published on 01 March 1995

Allogeneic blood stem cell transplantation in advanced hematologic cancers

artículo científico publicado en 1997

Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease

artículo científico publicado en 1995

Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.

artículo científico

Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management

artículo científico publicado en 1995

Allogeneic hematopoietic transplantation for chronic lymphocytic leukemia and lymphoma: potential for nonablative preparative regimens

artículo científico publicado en 2000

Allogeneic peripheral blood stem cell transplantation using normal patient-related pediatric donors

artículo científico publicado en 1996

Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer

scientific article published on 01 March 1998

Allogeneic stem cell transplant in renal failure: engraftment and prolonged survival, but high incidence of neurologic toxicity

scientific article published on 06 September 2011

Allogeneic stem cell transplantation for sickle cell disease. A study of patients' decisions

artículo científico publicado en 2001

Allogeneic stem cell transplantation with alemtuzumab-based conditioning for patients with advanced chronic myelogenous leukemia.

artículo científico publicado en 2009

Allogeneic transplant for CML in chronic phase after failure of imatinib. Not needed or needlessly neglected?

artículo científico publicado en 2020

Allogeneic transplant for peripheral T-cell lymphoma: a sparkle of hope and many questions

artículo científico publicado en 2011

Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimus

scientific article published on 01 December 1996

Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: experience in 44 consecutive patients

artículo científico publicado el 1 de agosto de 1997

Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning

artículo científico publicado en 2008

An update on options of therapy for aggressive mantle cell lymphoma

artículo científico publicado en 2020

Analysis of Chimerism Following Allogeneic Bone Marrow Transplantation by Fluorescent-in-Situ Hybridization ⬇️

artículo científico publicado el 1 de mayo de 1997

Aplastic anaemia in patient with glioblastoma multiforme treated with temozolomide.

artículo científico publicado en 2006

Arterial thrombosis in four patients treated with thalidomide

artículo científico publicado en 2005

Associations between acute gastrointestinal GvHD and the baseline gut microbiota of allogeneic hematopoietic stem cell transplant recipients and donors

artículo científico publicado en 2017

Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results

artículo científico publicado en 1994

Autologous and allogeneic transplantation for aggressive NHL.

artículo científico publicado en 2002

Autologous bone marrow transplantation for leukemia and lymphoma.

artículo científico publicado en 1996

Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance.

artículo científico publicado en 2007

Autologous stem cell transplant in human immunodeficiency virus-positive patients with lymphoid malignancies: focus on infectious complications

artículo científico publicado en 2012

Autologous transplant for primary mediastinal B-cell lymphoma

artículo científico publicado en 2009

BK virus infection is associated with hematuria and renal impairment in recipients of allogeneic hematopoetic stem cell transplants

artículo científico publicado en 2009

Baloxavir for the treatment of Influenza in allogeneic hematopoietic stem cell transplant recipients previously treated with Oseltamivir

artículo científico publicado en 2020

Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.

artículo científico publicado en 2013

Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma

scientific article published on 01 January 1997

Bortezomib and Immune Globulin Have Limited Effects on Donor-Specific HLA Antibodies in Haploidentical Cord Blood Stem Cell Transplantation: Detrimental Effect of Persistent Haploidentical Donor-Specific HLA Antibodies

artículo científico publicado en 2018

Breakthrough Bloodstream Infections Caused by Echinocandin-Resistant Candida tropicalis: An Emerging Threat to Immunocompromised Patients with Hematological Malignancies

artículo científico publicado en 2020

Busulfan or melphalan: is there a better conditioning regimen for allogeneneic transplantation?

artículo científico publicado en 2020

CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation

artículo científico publicado en 1995

Cardiac tamponade in a patient with chronic lymphocytic leukemia

artículo científico publicado en 2007

Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma

artículo científico publicado en 1999

Central nervous system relapse of lymphoid malignancies in adults: the role of high-dose chemotherapy

artículo científico publicado en 1997

Characterization of human hematopoietic stem cells

artículo científico publicado en 1990

Chimerism does not predict for outcome after alemtuzumab based conditioning

artículo científico publicado en 2007

Chronic graft-versus-host disease after allogeneic blood stem cell transplantation

artículo científico publicado en 2001

Chronic myelogenous leukemia: role of stem cell transplant in the imatinib era.

artículo científico publicado en 2011

Clinical activity of arsenic trioxide in Burkitt-like lymphoma

artículo científico publicado en 2003

Clinical and molecular epidemiology of human rhinovirus infections in patients with hematologic malignancy

artículo científico publicado en 2015

Clinical outcomes of patients with desmoplastic small round cell tumor of the peritoneum undergoing autologous HCT: a CIBMTR retrospective analysis

artículo científico publicado en 2012

Clinicopathologic features of late-onset veno-occlusive disease/sinusoidal obstruction syndrome after high dose intravenous busulfan and hematopoietic cell transplant

artículo científico publicado en 2012

Clofarabine as a bridge to hematopoietic stem cell transplant

artículo científico publicado en 2016

Clofarabine-associated acute kidney injury in patients undergoing hematopoietic stem cell transplant

artículo científico publicado en 2014

Colonization with Levofloxacin-Resistant Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients.

artículo científico publicado en 2018

Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic Leukemia.

artículo científico publicado en 2017

Combined use of tofacitinib (pan-JAK inhibitor) and ruxolitinib (a JAK1/2 inhibitor) for refractory T-cell prolymphocytic leukemia (T-PLL) with a JAK3 mutation

artículo científico publicado en 2019

Combining haplo-identical and cord blood stem cell grafts - might the whole be greater than the sum of its parts?

scientific article published on 12 February 2020

Comparison of Subcutaneous versus Intravenous Alemtuzumab for Graft-versus-Host Disease Prophylaxis with Fludarabine/Melphalan-Based Conditioning in Matched Unrelated Donor Allogeneic Stem Cell Transplantation

artículo científico publicado en 2015

Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.

artículo científico publicado en 2003

Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease

artículo científico publicado en 2010

Comparison of time to engraftment between autologous patients receiving washed versus non-washed cryopreserved peripheral blood stem cell products

scientific article published on 23 May 2018

Complete remission of refractory gestational trophoblastic disease with brain metastases treated with multicycle ifosfamide, carboplatin, and etoposide (ICE) and stem cell rescue

artículo científico publicado en 1997

Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis.

artículo científico publicado en 2016

Cord blood chimerism and relapse after haplo-cord transplantation.

artículo científico publicado en 2016

Cord blood maternal microchimerism following unrelated cord blood transplantation

artículo científico publicado en 2020

Cord blood transplant: the glass is half full--can we do better?

scientific article published on 01 April 2011

Cord blood transplants supported by unrelated donor CD34+ progenitor cells

artículo científico publicado en 2020

Cutting edge: activation of the p38 mitogen-activated protein kinase signaling pathway mediates cytokine-induced hemopoietic suppression in aplastic anemia

artículo científico publicado en 2002

Cytokine-dependent long-term culture of highly enriched precursors of hematopoietic progenitor cells from human bone marrow

artículo científico publicado en 1990

DAS181 for Treatment of Parainfluenza Virus Infections in Hematopoietic Stem Cell Transplant Recipients at a Single Center

artículo científico publicado en 2016

Detection and Characterization of Influenza B Virus With Reduced Neuraminidase Susceptibility in a Stem Cell Transplant Recipient

scientific article published on 18 November 2019

Differences in characteristics of US hematopoietic stem cell transplantation centers by proportion of racial or ethnic minorities

artículo científico publicado en 2005

Distinct functions of erythropoietin and stem cell factor are linked to activation of mTOR kinase signaling pathway in human erythroid progenitors

artículo científico publicado en 2012

Donor graft genotypes versus leukemia

scientific article published on 01 July 2019

Earlier may be better: the role of extracorporeal photopheresis (ECP) as prevention of GVHD after allogeneic transplant.

artículo científico publicado en 2017

Early human herpes virus type 6 reactivation in umbilical cord blood allogeneic stem cell transplantation.

artículo científico publicado en 2016

Echinocandin-resistant Candida tropicalis Bloodstream Infections

artículo científico publicado en 2017

Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation.

artículo científico publicado en 2006

Engraftment for CD34 selected stem cell products is not compromised by cryopreservation.

artículo científico publicado en 2015

Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy

scientific article published on 01 June 1997

Epidemiology of vancomycin-resistant enterococci among patients on an adult stem cell transplant unit: observations from an active surveillance program

artículo científico publicado en 2008

Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.

artículo científico publicado en 2009

Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation.

artículo científico publicado en 2009

Fatal CMV pneumonitis in a lymphoma patient treated with rituximab

artículo científico publicado en 2009

Fatigue and physical activity in patients undergoing hematopoietic stem cell transplant

artículo científico publicado en 2006

Feasibility of clofarabine cytoreduction before allogeneic transplant conditioning for refractory AML.

artículo científico publicado en 2010

Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant

artículo científico publicado en 2001

Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome

artículo científico publicado en 2005

Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease

scientific article published on 01 August 2000

Fludarabine-melphalan conditioning for AML and MDS: alemtuzumab reduces acute and chronic GVHD without affecting long-term outcomes

artículo científico publicado en 2009

Follicular lymphoma: a historical overview.

artículo científico publicado en 2007

Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir

artículo científico publicado en 1997

Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning

artículo científico publicado en 2016

Ganciclovir three times per week is not adequate to prevent cytomegalovirus reactivation after T cell-depleted marrow transplantation.

artículo científico publicado en 1994

Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804.

artículo científico publicado en 2007

Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients.

artículo científico publicado en 2014

Granulocyte Colony-Stimulating Factor Use after Autologous Peripheral Blood Stem Cell Transplantation: Comparison of Two Practices

artículo científico publicado en 2017

Granulocyte colony-stimulating factor-based stem cell mobilization in patients with sickle cell disease

artículo científico publicado en 2008

Haplo-cord transplant: HLA-matching determines graft dominance.

artículo científico publicado en 2016

Haploidentical vs haplo-cord transplant in adults under 60 years receiving fludarabine and melphalan conditioning

artículo científico publicado en 2019

Hematology and oncology clinical care during the coronavirus disease 2019 pandemic

artículo científico publicado en 2020

Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma

artículo científico publicado en 2013

Hematopoietic transplant-associated thrombotic microangiopathy: case report and review of diagnosis and treatments

artículo científico publicado en 2014

High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML).

artículo científico publicado en 2012

High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma

artículo científico publicado en 2019

High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome

artículo científico publicado en 1998

High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity

artículo científico publicado el 1 de abril de 1995

High-dose melphalan allows durable engraftment of allogeneic bone marrow

artículo científico publicado en 1995

High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplant

scientific article published on 01 August 2000

How we handled the dextran shortage: an alternative washing or dilution solution for cord blood infusions.

artículo científico publicado en 2015

Human CD34+ HLA-DR- bone marrow cells contain progenitor cells capable of self-renewal, multilineage differentiation, and long-term in vitro hematopoiesis

artículo científico publicado en 1991

Identification of high-risk amino-acid substitutions in hematopoietic cell transplantation: a challenging task.

artículo científico publicado en 2016

Identifying Inherited and Acquired Genetic Factors Involved in Poor Stem Cell Mobilization and Donor-Derived Malignancy

artículo científico publicado en 2016

Identifying familial myelodysplastic/acute leukemia predisposition syndromes through hematopoietic stem cell transplantation donors with thrombocytopenia

artículo científico publicado en 2012

Immune reconstitution after combined haploidentical and umbilical cord blood transplant

artículo científico publicado en 2013

Impact of a Multiplexed PCR Panel on Identifying Diarrheal Pathogens in Hematopoietic Cell Transplant Recipients

scientific article published on 05 November 2019

Impact of alemtuzumab dosing and low-dose total body irradiation on cytomegalovirus infection in allogeneic hematopoietic stem cell transplantation

scientific article published on 11 July 2020

Impact of disease burden at time of allogeneic stem cell transplantation in adults with acute myeloid leukemia and myelodysplastic syndromes

artículo científico publicado en 2005

Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma

artículo científico publicado en 2009

Impact of preexisting CNS involvement on the outcome of bone marrow transplantation in adult hematologic malignancies

scientific article published on 01 November 1996

Implementation of Molecular Surveillance After a Cluster of Fatal Toxoplasmosis at 2 Neighboring Transplant Centers.

artículo científico publicado en 2016

Incidence, significance, and persistence of human coronavirus infection in hematopoietic stem cell transplant recipients

scientific article published on 01 November 2018

Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR).

artículo científico publicado en 2008

Influence of related donor age on outcomes after peripheral blood stem cell transplantation.

artículo científico publicado en 2012

Intensive dose ifosfamide and etoposide with G-CSF for stem cell mobilization in patients with non-Hodgkin's lymphoma

artículo científico publicado en 1999

Interdigitating dendritic cell tumors in two patients exposed to topical calcineurin inhibitors

artículo científico publicado en 2007

Interferon-alpha and interleukin-2 as treatment for leukemia relapse after allogeneic bone marrow transplantation

artículo científico publicado el 1 de junio de 1995

Interleukin-2-activated autologous bone marrow and peripheral blood stem cells in the treatment of acute leukemia and lymphoma

artículo científico publicado en 1999

Intravesicular carboprost for the treatment of hemorrhagic cystitis after marrow transplantation

artículo científico publicado en 1995

Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.

artículo científico publicado en 2010

Invasive Aspergillus sinusitis during bone marrow transplantation

artículo científico publicado en 1997

Irreversible myelosuppression after fludarabine-melphalan conditioning: observations in patients with graft rejection

artículo científico publicado en 2004

Is less more? Viewpoint on empiric vancomycin therapy of fever and neutropenia after allogeneic stem cell transplantation

artículo científico publicado en 2020

Late relapse following allogeneic transplant for chronic lymphocytic leukemia: how good are graft versus leukemia effects?

scientific article published on 01 September 2008

Lenalidomide after stem-cell transplantation for multiple myeloma

artículo científico publicado en 2012

Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemias

artículo científico publicado en 2003

Long-term follow-up of nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma: The University of Chicago Experience

artículo científico publicado en 2005

Low incidence of CMV viremia and disease after allogeneic peripheral blood stem cell transplantation. Role of pretransplant ganciclovir and post-transplant acyclovir ⬇️

artículo científico publicado el 1 de mayo de 2003

Management of important adverse events associated with inotuzumab ozogamicin: expert panel review.

artículo científico publicado en 2018

Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect

artículo científico publicado en 1997

Methodological and logistical considerations to study design and data collection in racial/ethnic minority populations evaluating outcome disparity in hematopoietic cell transplantation

artículo científico publicado en 2009

Microchimerism and allogeneic transplantation: we need the proof in the pudding

artículo científico publicado en 2013

Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era.

artículo científico publicado en 2010

Mycobacterial spindle cell pseudotumour: epidemiology and clinical outcomes

artículo científico publicado en 2018

Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry.

artículo científico publicado en 2004

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantatio

artículo científico publicado en 2010

National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee

artículo científico publicado en 2011

Nonmyeloablative conditioning for relapsed follicular lymphoma

artículo científico publicado en 2008

Older age but not donor health impairs allogeneic granulocyte colony-stimulating factor (G-CSF) peripheral blood stem cell mobilization

artículo científico publicado en 2009

Order of patient entry influences outcome for metastatic renal cell cancer after non-myeloablative allogeneic stem cell transplantation.

artículo científico publicado en 2006

Osteopontin regulates actin cytoskeleton and contributes to cell proliferation in primary erythroblasts

artículo científico publicado en 2008

Outcome of lower-intensity allogeneic transplantation in non-Hodgkin lymphoma after autologous transplantation failure.

artículo científico publicado en 2011

Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant

artículo científico publicado en 2019

Outcomes of Allogeneic Stem Cell Transplant for Elderly Patients with Hematologic Malignancies

scientific article published on 28 December 2019

Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation

artículo científico publicado en 2007

Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence

artículo científico publicado en 2009

Paucity of HLA-identical unrelated donors for African-Americans with hematologic malignancies: the need for new donor options

artículo científico publicado en 2008

Performance Status and Comorbidity Predict Transplant-Related Mortality After Allogeneic Hematopoietic Cell Transplantation

artículo científico publicado en 2006

Peripheral-blood versus bone marrow stem cells

artículo científico publicado en 2013

Personalized treatment of lymphoma: promise and reality.

artículo científico publicado en 2011

Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive diseas

artículo científico publicado en 2010

Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantation

artículo científico publicado en 2011

Phase II study of a high-dose ifosfamide-based chemotherapy regimen with growth factor rescue in recurrent aggressive NHL. High response rates and limited toxicity, but limited impact on long-term survival

artículo científico publicado en 2001

Phase II study of autologous transplantation with interleukin-2-incubated peripheral blood stem cells and posttransplantation interleukin-2 in relapsed or refractory non-Hodgkin lymphoma

artículo científico publicado en 2004

Phase II study of immunomodulation with granulocyte-macrophage colony-stimulating factor, interleukin-2, and rituximab following autologous stem cell transplant in patients with relapsed or refractory lymphomas

artículo científico publicado en 2010

Pilot study of comprehensive geriatric assessment (CGA) in allogeneic transplant: CGA captures a high prevalence of vulnerabilities in older transplant recipients.

artículo científico publicado en 2012

Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning

artículo científico publicado en 2006

Pre-transplant serum ferritin is prognostic but is it useful?

artículo científico publicado en 2013

Pregnancy associated with lupus anticoagulant and heparin induced thrombocytopenia: management with a low molecular weight heparinoid.

artículo científico publicado en 1991

Preleukemic state preceding adult acute lymphoblastic leukemia

artículo científico publicado en 1990

Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation

artículo científico publicado en 2008

Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma.

artículo científico publicado en 2004

Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis--results of a crossover randomized study

artículo científico publicado en 2011

Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high risk

scientific article published on 10 February 2019

Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients

artículo científico publicado en 2015

Reduced duration of cytopenias following melphalan conditioning and autografting for multiple myeloma

artículo científico publicado en 2002

Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.

artículo científico publicado en 2016

Reduced-Intensity Allogeneic Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome Using Combined CD34-Selected Haploidentical Graft and a Single Umbilical Cord Unit Compared with Matched Unrelated Donor Stem Cells in Older Adults

artículo científico publicado en 2017

Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions

artículo científico publicado en 2011

Regimen-related toxicity after fludarabine-melphalan conditioning: a prospective study of 31 patients with hematologic malignancies

artículo científico publicado en 2003

Relapsing polychondritis: a paraneoplastic syndrome associated with myelodysplastic syndromes

artículo científico publicado en 1992

Remission of refractory gestational trophoblastic disease in the brain with ifosfamide, carboplatin, and etoposide (ICE): first report and review of literature

artículo científico publicado en 1997

Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation

artículo científico publicado en 1999

Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma.

artículo científico publicado en 1998

Safety and efficacy of plerixafor dose escalation for the mobilization of CD34 hematopoietic progenitor cells in patients with sickle cell disease: interim results

scholarly article by Farid Boulad et al published September 2018 in Haematologica

Safety and efficacy of plerixafor dose escalation for the mobilization of CD34+ hematopoietic progenitor cells in patients with sickle cell disease: interim results

artículo científico publicado en 2018

Safety and outcome after fludarabine-thiotepa-TBI conditioning for allogeneic transplantation: a prospective study of 30 patients with hematologic malignancies.

artículo científico publicado en 2003

Second allogeneic transplantation: ever? never? or sometimes

artículo científico publicado en 2016

Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant.

artículo científico publicado en 2008

Secondary lymphomas of the central nervous system: risk, prophylaxis and treatment.

scientific article published on January 2008

Severe intestinal graft-versus-host disease following autologous stem cell transplantation

artículo científico publicado en 2006

Simultaneous use of rhodamine 123, phycoerythrin, Texas red, and allophycocyanin for the isolation of human hematopoietic progenitor cells.

artículo científico publicado en 1991

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma

scientific article published on 01 December 2020

Stem cell transplantation eliminates alloantibody in a highly sensitized patient

artículo científico publicado en 2001

Stem cell transplantation in follicular lymphoma: progress at last?

artículo científico publicado en 2004

Studies of decitabine with allogeneic progenitor cell transplantation

artículo científico publicado en 1997

Successful allogeneic transplantation of patients with suspected prior invasive mold infection

scientific article published on 01 September 2007

Successful autologous stem cell collection in patients with chronic myeloid leukemia in complete cytogenetic response, with quantitative measurement of BCR-ABL expression in blood, marrow, and apheresis products

artículo científico publicado en 2008

Superiority of reduced-intensity conditioning for Hodgkin's lymphoma

artículo científico publicado en 2008

Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for

scientific article published on 08 September 2003

T-cell-depleted allogeneic transplant without donor leukocyte infusions results in excellent long-term survival in patients with multiply relapsed Lymphoma. Predictors for survival after transplant relapse

artículo científico publicado en 2010

T-cell-depleted reduced-intensity conditioning transplantation for lymphoma: do donor lymphocyte infusions really matter?

artículo científico publicado en 2011

Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation.

artículo científico publicado en 1999

Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1.

artículo científico publicado en 2000

Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortium

artículo científico publicado en 2010

The Addition of Low-Dose Total Body Irradiation to Fludarabine and Melphalan Conditioning in Haplocord Transplantation for High-Risk Hematological Malignancies.

artículo científico publicado en 2016

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia

artículo científico publicado en 2016

The eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data

artículo científico publicado en 2017

The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients

artículo científico publicado en 2014

The evolving role of autologous and allogeneic stem cell transplantation in follicular lymphoma.

artículo científico publicado en 2006

The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation

artículo científico publicado el 1 de junio de 1997

Therapeutic options for patients with Hodgkin's disease and non-Hodgkin's lymphoma who relapse after autologous transplant

artículo científico publicado en 2005

Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemia

artículo científico publicado en 1999

Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia

artículo científico publicado en 2001

Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma

artículo científico publicado en 1993

Thrombotic thrombocytopenic purpura after cephalosporin administration: a possible relationship

artículo científico publicado en 2003

Tisagenlecleucel cellular kinetics, dose, and immunogenicity in relation to clinical factors in relapsed/refractory DLBCL

artículo científico publicado en 2020

To the end of chronic lymphocytic leukemia: what should be the role of allogeneic transplant?

scientific article published on 01 June 2014

Tocilizumab, in search for a role in acute GVHD

artículo científico publicado en 2019

Toxicity of high dose BCNU: how much is too much?

artículo científico publicado en 2006

Toxicity of single daily dose gentamicin in stem cell transplantation

artículo científico publicado en 1999

Treatment of relapse after allogeneic bone marrow transplantation.

artículo científico publicado en 1996

Treatment of therapy-related myeloid neoplasms with high-dose cytarabine/mitoxantrone followed by hematopoietic stem cell transplant

artículo científico publicado en 2010

Umbilical cord blood transplantation supported by third-party donor cells: rationale, results, and applications

artículo científico publicado en 2012

Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomes

artículo científico publicado en 2009

Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma

artículo científico publicado en 2009

Unrelated donor transplantation over the age of 55. Are we merely getting (b)older?

scientific article published on 01 January 2005

Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial

artículo científico publicado en 2017

Validating and implementing the use of an infusion pump for the administration of thawed hematopoietic progenitor cells-a single-institution experience

artículo científico publicado en 2017

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda